Our formulas are not intended to diagnose, treat, cure, or prevent any form of disease or medical condition
Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle
There is not enough information on taking this medication in women who are pregnant or breast-feeding, therefore use is not advised
Most available safety data indicates that GHK-Cu peptide injections are generally safe to use under medical supervision, and adverse effects are generally mild
Thirdly, they are manufactured using recombinant methods, resulting in high patient costs
Key dates Information webinar: 6 July 2026, 15:00 to 17:00 CEST Stage 0, Expression of Interest (mandatory): 1 July to 10 September 2026 Stage 1, Short Proposal: 15 September to 29 October 2026 Full details of the ECTC 2026 are available on the ERDERA call page, including the pre-announcement of the call, the official call text and application documents published at the launch on 1 July